Wells Fargo analysts reiterated a Equal-Weight rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on January 20, 2026.
Alnylam Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $365.46 with a market capitalization of $54.5B.